363
CONCLUSION : Myocet improves the therapeutic index of doxorubicin by significantly reducing cardiotoxicity and grade 4 neutropenia and provides comparable antitumor efficacy , when used in combination with cyclophosphamide as first - line therapy for MBC .
 Chemical: Myocet; Chemical: doxorubicin; Disease: cardiotoxicity; Disease: neutropenia; Chemical: cyclophosphamide; Disease: MBC
Please list all entity words in the text that fit the category.Output format is "type1: word1; type2: word2". 
Option: Disease, Chemical 
Text: {0} 
Answer:
 Chemical: Myocet; Chemical: doxorubicin; Disease: cardiotoxicity; Disease: neutropenia; Chemical: cyclophosphamide; Disease: MBC